Citation: | ZHANG Fang, CHEN Guo-fan, WANG Ming-wei, REN Kai-han. Correlation between plasma homocysteine and blood pressure variability in patients with coronary heart disease complicated with hypertension[J]. Chinese Journal of General Practice, 2022, 20(7): 1106-1108. doi: 10.16766/j.cnki.issn.1674-4152.002534 |
[1] |
刘玮. 冠心病患者血尿酸及同型半胱氨酸水平与冠状动脉病变程度的关系及意义分析[J]. 中外医学研究, 2018, 16(8): 44-45. https://www.cnki.com.cn/Article/CJFDTOTAL-YJZY201808021.htm
LIU W. Analysis of significance and correlation between serum uric acid, homocysteine and the severity of coronary artery disease in patients with coronary heart disease[J]. Chinese And Foreign Medical Research, 2018, 16(8): 44-45. https://www.cnki.com.cn/Article/CJFDTOTAL-YJZY201808021.htm
|
[2] |
蒯琳, 洪梅. 血清同型半胱氨酸、高敏C反应蛋白、胱抑素C水平与冠状动脉粥样硬化的关系[J]. 中国医药导报, 2018, 15(35): 58-61. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201835014.htm
KUAI L, HONG M. Connection of homocysteine, high sensitivity C-reactive protein and cystatin C with coronary atherosclerosis[J]. China Medical Herald, 2018, 15(35): 58-61. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201835014.htm
|
[3] |
段平, 尹德录. 高同型半胱氨酸代谢酶基因多态性与冠心病发病关系的研究进展[J]. 中国循证心血管医学杂志, 2017, 9(2): 249-251. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX201702039.htm
DUAN P YIN D L. Research progress on the relationship between genetic polymorphisms of homocysteine metabolizing enzyme and onset of coronary heart disease[J]. Chinese Journal of Evidence-based Cardiovascular Medicine, 2017, 9(2): 249-251. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX201702039.htm
|
[4] |
汪浩伟, 文美, 杨建昌. 血压变异性与冠状动脉病变程度相关性分析[J]. 贵州医药, 2016, 40(8): 840-842. https://www.cnki.com.cn/Article/CJFDTOTAL-GZYI201608019.htm
WANG H W, WEN M, YANG J C. Correlation between blood pressure variability and severity of coronary artery disease[J]. Guizhou Medical Journal, 2016, 40(8): 840-842. https://www.cnki.com.cn/Article/CJFDTOTAL-GZYI201608019.htm
|
[5] |
LI S H, ZHU J M, WU L, et al. The association between plasma homocysteine and ambulatory blood pressure variability in patients with untreated hypertension[J]. Clin Chim Acta, 2018. DOI: 10.1016/j.cca.2017.11.042.
|
[6] |
《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治, 2019, 19(1): 1-44. https://www.cnki.com.cn/Article/CJFDTOTAL-XIXG201901003.htm
Writing group of 2018 Chinese guidelines for the management of hypertension. 2018 Chinese guidelines for the management of hypertension[J]. Chinese Journal of Cardiovascular Medicine, 2019, 19(1): 1-44. https://www.cnki.com.cn/Article/CJFDTOTAL-XIXG201901003.htm
|
[7] |
ABRAHAM W T, STEVENSON L W, BOURGE R C, et al. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: Complete follow-up results from the CHAMPION randomised trial[J]. Lancet, 2016, 387(10017): 453-461. doi: 10.1016/S0140-6736(15)00723-0
|
[8] |
曹明, 王奇军. H型高血压患者血浆同型半胱氨酸水平变化对动脉粥样硬化性疾病的影响[J]. 检验医学, 2019, 34(11): 1007-1010. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYY201911011.htm
CAO M, WANG Q J. Influence of plasma homocysteine level change on atherosclerosis in H-type hypertension patients[J]. Laboratory Medicine, 2019, 34(11): 1007-1010. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYY201911011.htm
|
[9] |
徐志娜, 周建松, 古忆, 等. 血浆同型半胱氨酸与冠心病的相关性及其与冠心病传统危险因素的关系[J]. 贵州医科大学学报, 2016, 41(11): 1318-1321. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYB201611018.htm
XU Z N, ZHOU J S, GU Y, et al. Study on Correlation between HCY and Coronary Heart Disease and Traditional Risk Factors of Coronary Heart Disease[J]. Journal of Guizhou Medical University, 2016, 41(11): 1318-1321. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYB201611018.htm
|
[10] |
唐亮, 乐建华, 李赛帅, 等. 高血压患者血压变异性与靶器官损害的关系分析[J]. 中国实用医药, 2020, 15(6): 40-41. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA202006017.htm
TANG L, LE J H, LI S S, et al. Relationship between blood pressure variability and target organ damage in patientswith hypertension[J]. China Practical Medicine, 2020, 15(6): 40-41. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA202006017.htm
|
[11] |
陈海荣, 李名兰, 潘碧云, 等. 血浆同型半胱氨酸水平与高血压患者血压变异性的相关性分析[J]. 内科急危重症杂志, 2020, 26(4): 280-282, 324. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW202004006.htm
CHEN H R, LI M L, PAN B Y, et al. Association between plasma homocysteine level and blood pressure variability in patients with hypertension[J]. Journal of Internal Intensive Medicine, 2020, 26(4): 280-282, 324. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW202004006.htm
|
[12] |
徐菲菲, 刘咏梅, 房振宇, 等. 原发性肾小球肾炎患者血浆高同型半胱氨酸水平的变化及与钙磷乘积和血尿酸的相关性分析[J]. 现代生物医学进展, 2020, 20(3): 558-560, 548. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202003034.htm
XU F F, LIU Y M, FANG Z Y, et al. Changes of Plasma Hcy in Patients with Primary Glomerulonephritis and Its Correlation with Calcium-phosphorus Product and Blood Uric Acid[J]. Progress in Modern Biomedicine, 2020, 20(3): 558-560, 548. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202003034.htm
|
[13] |
孙炜炜, 刘婷, 邵泽伟, 等. 冠心病患者血清同型半胱氨酸与血脂指标的相关性研究[J]. 中国卫生标准管理, 2017, 8(13): 124-126. https://www.cnki.com.cn/Article/CJFDTOTAL-WSBZ201713069.htm
SUN W W, LIU T, SHAO Z W, et al. The Correlation Research Between Serum Homocysteine and Blood Lipids in Patients With Coronary Diseas[J]. China Health Standard Management, 2017, 8(13): 124-126. https://www.cnki.com.cn/Article/CJFDTOTAL-WSBZ201713069.htm
|
[14] |
陈礼萍. 冠心病患者血浆同型半胱氨酸水平与血压变异性的相关性分析[D]. 昆明: 昆明医科大学, 2020.
CHEN L P. Correlation between plasma homocysteine level and blood pressure variability in patients with coronary heart disease[D]. Kunming: Kunming Medical University, 2020.
|
[15] |
杨晓明, 王审. 长期大剂量服用阿托伐他汀对老年高血压合并冠心病的疗效和安全性评价[J]. 中华全科医学, 2018, 16(12): 2035-2038. doi: 10.16766/j.cnki.issn.1674-4152.000555
YANG X M, WANG S. Efficacy and Safety of long term high-dose atorvastatin in elderly patients with hypertension complicated with coronary heart disease[J]. Chinese Journal of General Practice, 2018, 16(12): 2035-2038. doi: 10.16766/j.cnki.issn.1674-4152.000555
|
[16] |
DHAR P, SHARMA V K, DAS S K, et al. Differential responses of autonomic function in sea level residents, acclimatized lowlanders at>3 500 m and Himalayan high altitude natives at >3 500 m: A cross-sectional study[J]. Respir Physiol Neurobiol, 2018. DOI: 10.1016/j.resp.2018.04.002.
|